Progestogen-only injectable contraceptive

Long-acting reversible contraceptives (LARC)
Background
Type Hormonal
First use 1957[1]
Pregnancy rates (first year)
Perfect use ?
Typical use ?
Usage
Reversibility Yes
User reminders ?
Advantages and disadvantages
STD protection No

Progestogen-only injectable contraceptives (POICs) are a form of hormonal contraception and progestogen-only contraception that are administered by injection and providing long-lasting birth control.[2][3] As opposed to combined injectable contraceptives, they contain only a progestogen without an estrogen, and include two progestin preparations:[2][3]

See also

References

  1. Singh M, Saxena BB, Singh R, Kaplan J, Ledger WJ (1997). "Contraceptive efficacy of norethindrone encapsulated in injectable biodegradable poly-dl-lactide-co-glycolide microspheres (NET-90): phase III clinical study". Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception. 13 (1): 1–11. PMID 9181181. In 1957, Karl Junkmann developed norethindrone enanthate (NET-EN or Noristeroir), the first injectable contraceptive which was injected every two months [1].
  2. 1 2 P. F. A. van Look; Kristian Heggenhougen; Stella R. Quah (January 2011). Sexual and Reproductive Health: A Public Health Perspective. Academic Press. pp. 82–. ISBN 978-0-12-385009-6.
  3. 1 2 3 4 Nagrath Arun; Malhotra Narendra; Seth Shikha (15 December 2012). Progress in Obstetrics and Gynecology--3. Jaypee Brothers Medical Publishers Pvt. Ltd. pp. 416–. ISBN 978-93-5090-575-3.
  4. Mary Lee; Archana Desai (2007). Gibaldi's Drug Delivery Systems in Pharmaceutical Care. ASHP. pp. 328–. ISBN 978-1-58528-136-7.
  5. Chaudhuri (1 January 2007). Practice Of Fertility Control: A Comprehensive Manual (7Th Edition). Elsevier India. pp. 154–. ISBN 978-81-312-1150-2.


This article is issued from Wikipedia - version of the 12/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.